ARS Investment Partners LLC reduced its stake in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) by 0.7% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 487,626 shares of the semiconductor company's stock after selling 3,255 shares during the quarter. Lam Research makes up about 3.7% of ARS Investment Partners LLC's holdings, making the stock its 3rd biggest holding. ARS Investment Partners LLC's holdings in Lam Research were worth $35,221,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also added to or reduced their stakes in LRCX. Smallwood Wealth Investment Management LLC purchased a new position in Lam Research during the 1st quarter valued at $26,000. West Paces Advisors Inc. purchased a new position in Lam Research during the 4th quarter valued at $27,000. Mpwm Advisory Solutions LLC purchased a new position in Lam Research during the 4th quarter valued at $27,000. Park Square Financial Group LLC purchased a new position in Lam Research during the 4th quarter valued at $31,000. Finally, Putney Financial Group LLC purchased a new stake in shares of Lam Research in the 4th quarter worth about $36,000. 84.61% of the stock is owned by hedge funds and other institutional investors.
Lam Research Stock Performance
Shares of Lam Research stock opened at $100.33 on Wednesday. The stock has a market cap of $126.98 billion, a price-to-earnings ratio of 24.12, a PEG ratio of 1.28 and a beta of 1.65. The firm's 50-day moving average is $97.90 and its 200 day moving average is $84.22. Lam Research Corporation has a 1 year low of $56.32 and a 1 year high of $108.02. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.21 and a quick ratio of 1.55.
Lam Research (NASDAQ:LRCX - Get Free Report) last posted its earnings results on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.12. The business had revenue of $5.17 billion for the quarter, compared to analysts' expectations of $4.99 billion. Lam Research had a net margin of 29.07% and a return on equity of 58.17%. The business's revenue for the quarter was up 33.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.03 EPS. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. Sell-side analysts anticipate that Lam Research Corporation will post 3.71 EPS for the current fiscal year.
Analyst Ratings Changes
A number of research firms have recently weighed in on LRCX. Barclays set a $83.00 target price on shares of Lam Research and gave the stock an "equal weight" rating in a research report on Monday, July 28th. Stifel Nicolaus upped their target price on shares of Lam Research from $92.00 to $110.00 and gave the stock a "buy" rating in a research report on Tuesday, July 29th. Erste Group Bank began coverage on shares of Lam Research in a research report on Thursday, August 14th. They issued a "buy" rating on the stock. Raymond James Financial upped their target price on shares of Lam Research from $90.00 to $110.00 and gave the stock an "outperform" rating in a research report on Thursday, July 31st. Finally, Mizuho upped their target price on shares of Lam Research from $115.00 to $120.00 and gave the stock an "outperform" rating in a research report on Friday, August 1st. Twenty investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $107.09.
Check Out Our Latest Stock Analysis on Lam Research
About Lam Research
(
Free Report)
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.